Core Points - A class action lawsuit has been filed against Orthofix Medical, Inc. for failing to disclose inappropriate conduct by certain management team members during the class period from October 11, 2022, to September 12, 2023 [1][3] - Following the announcement of the termination of three management team members due to inappropriate conduct, Orthofix's share price dropped by approximately 30%, from $18.63 to $13.01 per share [2] Company Actions - On September 12, 2023, Orthofix's Board of Directors unanimously decided to terminate and replace three members of the management team after an investigation revealed repeated inappropriate conduct [2] - The class action alleges that the company failed to disclose this misconduct, which significantly impacted investor confidence and share price [3] Legal Information - Investors have until October 21, 2024, to apply to be appointed as lead plaintiff in the class action lawsuit [1] - The law firm Kirby McInerney LLP is representing the investors and has a history of successful recoveries in securities litigation [5]
Kirby McInerney LLP Reminds Orthofix Medical, Inc. (OFIX) Investors of Class Action Filing and Encourages Investors to Contact the Firm